Valuation (86%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 2.41 | N/A |
PEG Ratio (TTM) | -0.16 | N/A |
P/S Ratio (TTM) | 0.08 | N/A |
P/B Ratio (TTM) | 0.16 | N/A |
P/FCF Ratio (TTM) | 0.11 | N/A |
Price to 5YR AVG Earnings Ratio | 2.61 | N/A |
Price to 5YR AVG FCF Ratio | 0.58 | N/A |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.61% | N/A |
ROE (TTM) | 7.43% | N/A |
Net Profit Margin (TTM) | 3.35% | N/A |
ROIC 5YR AVG | 37.63% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -9.46% | 4.15% | 14.25% |
Revenue | 3.86% | 9.07% | 7.82% |
Net Income | -9.02% | 5.97% | 15.23% |
Cash Flow | 252.71% | 38.60% | 49.81% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | N/A |
Quick Ratio (TTM) | N/A | N/A |
D/E Ratio (TTM) | 0.46 | N/A |
Interest Coverage (TTM) | 16.61 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 1.16 | N/A |
LTL to 5YR AVG FCF | 1.47 | N/A |
Shares Outstanding Growth 5YR AVG | 1.09% | N/A |